STOCK TITAN

AEHR TEST SYSTEMS (AEHR) COO exercises 15,000 options and sells 15,000 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a same-day option exercise and sale sequence. He exercised options to acquire 15,000 shares of common stock at an exercise price of $9.45 per share, then sold 7,500 shares at $130.9549 and another 7,500 shares at $131.0950 per share. Following the derivative exercises, he reported remaining direct option holdings of 31,330 and 28,088 options in the respective grants. One reported amount of common stock includes shares subject to unvested restricted stock units.

Positive

  • None.

Negative

  • None.
Insider ENGINEER ADIL
Role Chief Operating Officer
Sold 15,000 shs ($1.97M)
Approx. gross sale proceeds $1.97M
Approx. exercise cost $142K
Approx. pre-tax spread $1.82M
Type Security Shares Price Value
Exercise Option (right to buy) 7,500 $0.00 $0.00
Exercise Non-Qualified Option (right to buy) 7,500 $0.00 $0.00
Exercise Common Stock 15,000 $9.45 $142K
Sale Common Stock 7,500 $130.9549 $982K
Sale Common Stock F1 7,500 $131.095 $983K
Holdings After Transaction: Option (right to buy) — 31,330 shares (Direct); Non-Qualified Option (right to buy) — 28,088 shares (Direct); Common Stock — 46,977 shares (Direct)
Footnotes (1)
  1. F1. The amount reported includes shares subject to unvested restricted stock units.
Options Exercised 15,000 shares Common stock acquired via option exercises on 2026-08-12
Exercise Price $9.45 per share Exercise or conversion price of options expiring 2029-04-06
Shares Sold (Block 1) 7,500 shares at $130.9549 Common stock sale on 2026-08-12
Shares Sold (Block 2) 7,500 shares at $131.0950 Common stock sale on 2026-08-12
Remaining Options Grant 1 31,330 options Direct holdings after option exercise in first grant
Remaining Options Grant 2 28,088 options Direct holdings after option exercise in non-qualified grant
Non-Qualified Option financial
"Security title listed as “Non-Qualified Option (right to buy)”"
restricted stock units financial
"Footnote states amount includes shares subject to unvested restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 regulatory
"Checkbox and footnotes address Rule 10b5-1 trading plan status"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
derivative security financial
"Transaction code description notes exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

What did AEHR COO Adil Engineer report on this Form 4 for AEHR?

Adil Engineer reported exercising options for 15,000 shares of AEHR common stock at $9.45 per share, then selling 15,000 shares in two transactions around $131 per share. The filing also reports updated remaining option holdings.

How many AEHR shares did the COO sell in this Form 4 filing?

The COO reported selling a total of 15,000 shares of AEHR common stock. The sales were split into two blocks of 7,500 shares each, at prices of $130.9549 and $131.0950 per share, respectively.

At what price did the AEHR COO exercise stock options in this Form 4?

He exercised stock options covering 15,000 shares of AEHR common stock at an exercise price of $9.45 per share. These options were reported as expiring on April 6, 2029, with an original exercise date of May 6, 2022.

What option holdings does the AEHR COO report remaining after these transactions?

After exercising options, the COO reports remaining direct holdings of 31,330 options in one grant and 28,088 options in another. These figures reflect derivative positions titled “Option (right to buy)” and “Non-Qualified Option (right to buy)” on AEHR common stock.

Does the AEHR Form 4 mention restricted stock units for the COO?

Yes. A footnote states one reported amount of common stock includes shares subject to unvested restricted stock units. This clarifies that part of the reported equity position consists of RSUs that have not yet vested into unrestricted shares.

Were the AEHR COO’s trades made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as an affirmative plan. No footnote describes these trades as pursuant to a trading plan, so the filing does not characterize them as pre-arranged under Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ENGINEER ADIL

(Last)(First)(Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/12/2026M15,000A$9.4561,977D
Common Stock08/12/2026S7,500D$130.954954,477D
Common Stock08/12/2026S7,500D$131.09546,977(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy)$9.4508/12/2026M7,50005/06/202204/06/2029Common Stock7,500$031,330D
Non-Qualified Option (right to buy)$9.4508/12/2026M7,50005/06/202204/06/2029Common Stock7,500$028,088D
Explanation of Responses:
1. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)